{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:36:37Z","timestamp":1787067397735,"version":"build-2736575974"},"reference-count":92,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2 P50 AA011999"],"award-info":[{"award-number":["2 P50 AA011999"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5 P42 ES010337"],"award-info":[{"award-number":["5 P42 ES010337"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5 U01 AA021856"],"award-info":[{"award-number":["5 U01 AA021856"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["Z111107054511064"],"award-info":[{"award-number":["Z111107054511064"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2016.00047","type":"journal-article","created":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T01:37:26Z","timestamp":1455586646000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":62,"title":["Promising Therapy Candidates for Liver Fibrosis"],"prefix":"10.3389","volume":"7","author":[{"given":"Ping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Yen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Kisseleva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jhep.2010.03.016","article-title":"Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis","volume":"53","author":"Anstee","year":"2010","journal-title":"J. Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1002\/hep.25938","article-title":"Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent","volume":"56","author":"Aoyama","year":"2012","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/liv.12570","article-title":"The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis","volume":"35","author":"Barreyro","year":"2015","journal-title":"Liver Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nm.2208","article-title":"Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment","volume":"16","author":"Barry-Hamilton","year":"2010","journal-title":"Nat. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"468.e10","DOI":"10.1053\/j.gastro.2015.04.009","article-title":"Hepatocyte nicotinamide adenine dinucleotide phosphate reduced oxidase 4 regulates stress signaling, fibrosis, and insulin sensitivity during development of Steatohepatitis in mice","volume":"149","author":"Bettaieb","year":"2015","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1189\/jlb.1008585","article-title":"HMGB1 loves company","volume":"86","author":"Bianchi","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1097\/MCG.0000000000000391","article-title":"Role of gut microbiota in liver disease","volume":"49","author":"Brenner","year":"2015","journal-title":"J. Clin. Gastroenterol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1124\/jpet.103.060129","article-title":"The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse","volume":"308","author":"Canbay","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.dld.2010.10.015","article-title":"Gut microbiota and probiotics in chronic liver diseases","volume":"43","author":"Cesaro","year":"2011","journal-title":"Dig. Liver Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1097\/TP.0b013e3182884866","article-title":"Role of integrin \u03b1v\u03b26 in the pathogenesis of ischemia-related biliary fibrosis after liver transplantation","volume":"95","author":"Chen","year":"2013","journal-title":"Transplantation"},{"key":"B11","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1089\/jmf.2007.0691","article-title":"Hepatoprotective effects of an anthocyanin fraction from purple-fleshed sweet potato against acetaminophen-induced liver damage in mice","volume":"12","author":"Choi","year":"2009","journal-title":"J. Med. Food."},{"key":"B12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.molmed.2015.09.004","article-title":"The Therapeutic Promise of mesenchymal stem cells for liver restoration","volume":"21","author":"Christ","year":"2015","journal-title":"Trends Mol. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/hep.24206","article-title":"Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis","volume":"53","author":"Chu","year":"2011","journal-title":"Hepatology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1136\/gutjnl-2013-306484","article-title":"Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice","volume":"64","author":"Coombes","year":"2015","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/sj.bjp.0706172","article-title":"Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis","volume":"145","author":"de Gouville","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1358\/dnp.2006.19.2.977444","article-title":"Inhibition of ALK5 as a new approach to treat liver fibrotic diseases","volume":"19","author":"de Gouville","year":"2006","journal-title":"Drug News Perspect."},{"key":"B17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.abb.2007.04.016","article-title":"NOX in liver fibrosis","volume":"462","author":"De Minicis","year":"2007","journal-title":"Arch. Biochem. Biophys."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/hep.23804","article-title":"Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis","volume":"52","author":"De Minicis","year":"2010","journal-title":"Hepatology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1136\/gut.2006.111617","article-title":"Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential","volume":"57","author":"di Bonzo","year":"2008","journal-title":"Gut"},{"key":"B20","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/labinvest.2012.45","article-title":"Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis","volume":"92","author":"Dixon","year":"2012","journal-title":"Lab. Invest."},{"key":"B21","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1478-3231.2011.02724.x","article-title":"The traditional ayurvedic medicine, Eugenia jambolana (Jamun fruit), decreases liver inflammation, injury and fibrosis during cholestasis","volume":"32","author":"Donepudi","year":"2012","journal-title":"Liver Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e82190","DOI":"10.1371\/journal.pone.0082190","article-title":"Attenuation of CCl4-induced hepatic fibrosis in mice by vaccinating against TGF-\u03b21","volume":"8","author":"Fan","year":"2013","journal-title":"PLoS ONE"},{"key":"B23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.taap.2014.08.006","article-title":"TGF-\u03b21-elevated TRPM7 channel regulates collagen expression in hepatic stellate cells via TGF-\u03b21\/Smad pathway","volume":"280","author":"Fang","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.taap.2013.08.009","article-title":"TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways","volume":"272","author":"Fang","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.trsl.2015.08.002","article-title":"Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence","volume":"167","author":"Federico","year":"2015","journal-title":"Transl. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"22672","DOI":"10.1074\/jbc.M114.552141","article-title":"High mobility group box-1 (HMGB1) participates in the pathogenesis of alcoholic liver disease (ALD)","volume":"289","author":"Ge","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10238-013-0229-6","article-title":"Inhibition of connective tissue growth factor suppresses hepatic stellate cell activation in vitro and prevents liver fibrosis in vivo","volume":"14","author":"Hao","year":"2014","journal-title":"Clin. Exp. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/hep.26321","article-title":"Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice","volume":"58","author":"Hartmann","year":"2013","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1517\/13543784.2015.997874","article-title":"Early to Phase II drugs currently under investigation for the treatment of liver fibrosis","volume":"24","author":"Hauff","year":"2015","journal-title":"Expert Opin. Investig. Drugs"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e70599","DOI":"10.1371\/journal.pone.0070599","article-title":"Vismodegib suppresses TRAIL-mediated liver injury in a mouse model of nonalcoholic steatohepatitis","volume":"8","author":"Hirsova","year":"2013","journal-title":"PLoS ONE"},{"key":"B31","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.4049\/jimmunol.1202184","article-title":"A novel small-molecule enantiomeric analogue of traditional (-)-morphinans has specific TLR9 antagonist properties and reduces sterile inflammation-induced organ damage","volume":"190","author":"Hoque","year":"2013","journal-title":"J. Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"G1171","DOI":"10.1152\/ajpgi.00352.2011","article-title":"P2X7 receptor-mediated purinergic signaling promotes liver injury in acetaminophen hepatotoxicity in mice","volume":"302","author":"Hoque","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1021\/jf904407x","article-title":"Effect of anthocyanin-rich extract from black rice (Oryza sativa L. Japonica) on chronically alcohol-induced liver damage in rats","volume":"58","author":"Hou","year":"2010","journal-title":"J Agric. Food Chem."},{"key":"B34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3892\/mmr.2013.1807","article-title":"P2X7 blockade attenuates mouse liver fibrosis","volume":"9","author":"Huang","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"B35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.freeradbiomed.2012.05.007","article-title":"Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4\/NOX1 inhibitor in vivo","volume":"53","author":"Jiang","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1136\/gut.2009.204354","article-title":"Signals from dying hepatocytes trigger growth of liver progenitors","volume":"59","author":"Jung","year":"2010","journal-title":"Gut"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s10495-013-0896-5","article-title":"Combined effects of an antioxidant and caspase inhibitor on the reversal of hepatic fibrosis in rats","volume":"18","author":"Kim do","year":"2013","journal-title":"Apoptosis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jhep.2006.04.014","article-title":"Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis","volume":"45","author":"Kisseleva","year":"2006","journal-title":"J. Hepatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.jss.2013.03.023","article-title":"Eritoran attenuates tissue damage and inflammation in hemorrhagic shock\/trauma","volume":"184","author":"Korff","year":"2013","journal-title":"J. Surg. Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1053\/j.gastro.2012.09.008","article-title":"Sterile inflammation in the liver","volume":"143","author":"Kubes","year":"2012","journal-title":"Gastroenterology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00262-015-1653-0","article-title":"Cutaneous keratoacanthomas\/squamous cell carcinomas associated with neutralization of transforming growth factor \u03b2 by the monoclonal antibody fresolimumab (GC1008)","volume":"64","author":"Lacouture","year":"2015","journal-title":"Cancer Immunol. Immunother."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jhep.2009.01.028","article-title":"Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis","volume":"50","author":"Li","year":"2009","journal-title":"J. Hepatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.jhep.2010.08.028","article-title":"Sphingosine 1-phosphate (S1P)\/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility","volume":"54","author":"Li","year":"2011","journal-title":"J. Hepatol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/cmi.2010.57","article-title":"Implications of the immunoregulatory functions of mesenchymal stem cells in the treatment of human liver diseases","volume":"8","author":"Lin","year":"2011","journal-title":"Cell Mol. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e54499","DOI":"10.1371\/journal.pone.0054499","article-title":"Transforming growth factor \u03b2 neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats","volume":"8","author":"Ling","year":"2013","journal-title":"PLoS ONE"},{"key":"B46","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1186\/1755-1536-5-S1-S24","article-title":"CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis","volume":"5","author":"Lipson","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1136\/gutjnl-2014-307362","article-title":"Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis","volume":"67","author":"Machado","year":"2014","journal-title":"Gut"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1002\/hep.25801","article-title":"Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure","volume":"56","author":"Marques","year":"2012","journal-title":"Hepatology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1126\/science.1195491","article-title":"Intravascular danger signals guide neutrophils to sites of sterile inflammation","volume":"330","author":"McDonald","year":"2010","journal-title":"Science"},{"key":"B50","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2119\/molmed.2014.00076","article-title":"Toll-like receptor 4 (TLR4) antagonist eritoran tetrasodium attenuates liver ischemia and reperfusion injury through inhibition of high-mobility group box protein B1 (HMGB1) Signaling","volume":"20","author":"McDonald","year":"2015","journal-title":"Mol. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"key":"B52","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1159\/000341704","article-title":"TGF-\u03b2 signaling in onset and progression of hepatocellular carcinoma","volume":"30","author":"Meindl-Beinker","year":"2012","journal-title":"Dig. Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/hep.22758","article-title":"Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats","volume":"49","author":"Mejias","year":"2009","journal-title":"Hepatology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e90353","DOI":"10.1371\/journal.pone.0090353","article-title":"Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGF\u03b2) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma","volume":"9","author":"Morris","year":"2014","journal-title":"PLoS ONE"},{"key":"B56","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2005.06.015","article-title":"Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term","volume":"44","author":"Neef","year":"2006","journal-title":"J. Hepatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1002\/hep.22397","article-title":"Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways","volume":"48","author":"Nitta","year":"2008","journal-title":"Hepatology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1002\/hep.23019","article-title":"Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production","volume":"50","author":"Omenetti","year":"2009","journal-title":"Hepatology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/labinvest.3700537","article-title":"Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation","volume":"87","author":"Omenetti","year":"2007","journal-title":"Lab. Invest."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.jhep.2012.07.008","article-title":"CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver","volume":"57","author":"Oo","year":"2012","journal-title":"J. Hepatol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.2967\/jnumed.111.092809","article-title":"PET with the 89Zr-labeled transforming growth factor-\u03b2 antibody fresolimumab in tumor models","volume":"52","author":"Oude Munnink","year":"2011","journal-title":"J. Nucl. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1089\/ars.2013.5619","article-title":"Role of NADPH oxidases in liver fibrosis","volume":"20","author":"Paik","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e23943","DOI":"10.1371\/journal.pone.0023943","article-title":"Hedgehog signaling antagonist promotes regression of both liver fibrosis and hepatocellular carcinoma in a murine model of primary liver cancer","volume":"6","author":"Philips","year":"2011","journal-title":"PLoS ONE"},{"key":"B64","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1002\/hep.21664","article-title":"Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C","volume":"46","author":"Pockros","year":"2007","journal-title":"Hepatology"},{"key":"B65","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.jhep.2007.11.021","article-title":"Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies","volume":"48","author":"Popov","year":"2008","journal-title":"J. Hepatol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1007\/s11095-010-0246-z","article-title":"Inhibition of endogenous hedgehog signaling protects against acute liver injury after ischemia reperfusion","volume":"27","author":"Pratap","year":"2010","journal-title":"Pharm. Res."},{"key":"B67","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1021\/mp200115v","article-title":"Cyclopamine attenuates acute warm ischemia reperfusion injury in cholestatic rat liver: hope for marginal livers","volume":"8","author":"Pratap","year":"2011","journal-title":"Mol. Pharm."},{"key":"B68","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3109\/1061186X.2012.719900","article-title":"Attenuation of early liver fibrosis by pharmacological inhibition of smoothened receptor signaling","volume":"20","author":"Pratap","year":"2012","journal-title":"J. Drug Target"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1053\/j.gastro.2006.01.036","article-title":"The bone marrow functionally contributes to liver fibrosis","volume":"130","author":"Russo","year":"2006","journal-title":"Gastroenterology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1053\/j.gastro.2010.05.005","article-title":"Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice","volume":"139","author":"Scholten","year":"2010","journal-title":"Gastroenterology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ajpath.2011.03.049","article-title":"Migration of fibrocytes in fibrogenic liver injury","volume":"179","author":"Scholten","year":"2011","journal-title":"Am. J. Pathol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1172\/JCI66028","article-title":"Evolving therapies for liver fibrosis","volume":"123","author":"Schuppan","year":"2013","journal-title":"J. Clin. Invest."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1002\/hep.27348","article-title":"Mouse hepatocyte overexpression of NF-\u03baB-inducing kinase (NIK) triggers fatal macrophage-dependent liver injury and fibrosis","volume":"60","author":"Shen","year":"2014","journal-title":"Hepatology"},{"key":"B74","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.cellsig.2013.11.020","article-title":"\u03b2-Lapachone alleviates alcoholic fatty liver disease in rats","volume":"26","author":"Shin","year":"2014","journal-title":"Cell. Signal."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1478.e8","DOI":"10.1053\/j.gastro.2009.06.051","article-title":"Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease","volume":"137","author":"Syn","year":"2009","journal-title":"Gastroenterology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"7812","DOI":"10.1073\/pnas.0832466100","article-title":"Transglutaminase 2-\/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells","volume":"100","author":"Szondy","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B77","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2249.2011.04471.x","article-title":"Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease","volume":"166","author":"Tang","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/hep.23368","article-title":"Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice","volume":"51","author":"Taura","year":"2010","journal-title":"Hepatology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejphar.2014.02.001","article-title":"Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme","volume":"728","author":"Tayel","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s10620-014-3167-6","article-title":"Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model","volume":"59","author":"Thapaliya","year":"2014","journal-title":"Dig. Dis. Sci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ki.2011.33","article-title":"A phase 1, single-dose study of fresolimumab, an anti-TGF-\u03b2 antibody, in treatment-resistant primary focal segmental glomerulosclerosis","volume":"79","author":"Trachtman","year":"2011","journal-title":"Kidney Int."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1002\/hep.21921","article-title":"Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats","volume":"46","author":"Tugues","year":"2007","journal-title":"Hepatology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/hep.21849","article-title":"Role of alphavbeta6 integrin in acute biliary fibrosis","volume":"46","author":"Wang","year":"2007","journal-title":"Hepatology"},{"key":"B84","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3892\/ijmm.2011.594","article-title":"IL-17 expression is correlated with hepatitis B-related liver diseases and fibrosis","volume":"27","author":"Wang","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ni.3002","article-title":"Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications","volume":"15","author":"Wang","year":"2014","journal-title":"Nat. Immunol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1053\/j.gastro.2014.05.001","article-title":"The portal fibroblast: not just a poor man's stellate cell","volume":"147","author":"Wells","year":"2014","journal-title":"Gastroenterology"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/hep.23167","article-title":"Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis","volume":"50","author":"Witek","year":"2009","journal-title":"Hepatology"},{"key":"B88","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/cpr.12165","article-title":"Signalling pathways involved in the process of mesenchymal stem cells differentiating into hepatocytes","volume":"48","author":"Ye","year":"2015","journal-title":"Cell Prolif."},{"key":"B89","doi-asserted-by":"publisher","first-page":"G907","DOI":"10.1152\/ajpgi.00420.2004","article-title":"Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats","volume":"288","author":"Yoshiji","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"23337","DOI":"10.1074\/jbc.M700194200","article-title":"Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition","volume":"282","author":"Zeisberg","year":"2007","journal-title":"J. Biol. Chem."},{"key":"B91","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1159\/000369746","article-title":"PTPRO-associated hepatic stellate cell activation plays a critical role in liver fibrosis","volume":"35","author":"Zhang","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/eji.201141933","article-title":"IL-17 neutralization significantly ameliorates hepatic granulomatous inflammation and liver damage in Schistosoma japonicum infected mice","volume":"42","author":"Zhang","year":"2012","journal-title":"Eur. J. Immunol."}],"container-title":["Frontiers in Physiology"],"original-title":[],"deposited":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T14:41:32Z","timestamp":1456929692000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fphys.2016.00047\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,16]]},"references-count":92,"URL":"https:\/\/doi.org\/10.3389\/fphys.2016.00047","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,16]]}}}